Induction of human embryonal carcinoma cell differentiation using N,N′-hexamethylene bisacetamide in vitro
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 36 (1) , 69-78
- https://doi.org/10.1016/0090-8258(90)90111-w
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Capacity for Differentiation and Production of Human Chorionic Gonadotropin and α-Fetoprotein in Human Embryonal Carcinoma Cell LinesInternational Journal of Gynecological Pathology, 1988
- In vitro and in vivo studies of the production of placental proteins (HCG, SP1, PPs) in human choriocarcinoma cell linesArchiv für Gynäkologie, 1987
- Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer.Journal of Clinical Oncology, 1986
- Characterization of human embryonal carcinoma cell lines derived from testicular germ-cell tumorsDifferentiation, 1985
- Immunochemistry of Human Teratocarcinoma Stem CellsPublished by Springer Nature ,1985
- Differentiation modifiersCancer, 1984
- Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitroDevelopmental Biology, 1984
- Polar solvents: a novel class of antineoplastic agents.Journal of Clinical Oncology, 1984
- Mouse teratocarcinoma cells: Prospects for the study of embryogenesis and neoplasiaCell, 1981
- CLASSIFICATION OF ENDODERMAL SINUS TUMOUR (MESOBLASTOMA VITELLINUM) AND SO‐CALLED “EMBRYONAL CARCINOMA” OF THE OVARYActa Pathologica Microbiologica Scandinavica, 1965